Beneficial effects of dietary omega-3 polyunsaturated fatty acid on toxin-induced neuronal degeneration in an animal model of Parkinson's disease

被引:167
作者
Bousquet, M. [1 ,3 ]
Saint-Pierre, M. [2 ]
Julien, C. [1 ,3 ]
Salem, N., Jr. [5 ]
Cicchetti, F. [2 ,4 ]
Calon, F. [1 ,3 ]
机构
[1] CHUQ, CHU Laval, Ctr Res Endocrinol Mol & Oncol, Quebec City, PQ G1V 4G2, Canada
[2] CHUQ, CHU Laval, Ctr Res Neurosci, Quebec City, PQ, Canada
[3] Univ Laval, Fac Pharm, Quebec City, PQ, Canada
[4] Univ Laval, Dept Med, Quebec City, PQ G1K 7P4, Canada
[5] NIAAA, Sect Nutr Neurosci, Lab Membrane Biochem & Biophys, Div Intramural Clin & Biol Res, Rockville, MD 20852 USA
关键词
MPTP; neuroprotection; DHA; dopamine;
D O I
10.1096/fj.07-9677com
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
In this study, we examined whether omega-3 (n-3) polyunsaturated fatty acids (PUFAs) may exert neuroprotective action in Parkinson's disease, as previously shown in Alzheimer's disease. We exposed mice to either a control or a high n-3 PUFA diet from 2 to 12 months of age and then treated them with the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP; 140 mg/kg in 5 days). High n-3 PUFA dietary consumption completely prevented the MPTP-induced decrease of tyrosine hydroxylase (TH)-labeled nigral cells (P<0.01 vs. MPTP mice on control diet), Nurr1 mRNA (P<0.01 vs. MPTP mice on control diet), and dopamine transporter mRNA levels (P<0.05 vs. MPTP mice on control diet) in the substantia nigra. Although n-3 PUFA dietary treatment had no effect on striatal dopaminergic terminals, the high n-3 PUFA diet protected against the MPTP-induced decrease in dopamine (P<0.05 vs. MPTP mice on control diet) and its metabolite dihydroxyphenylacetic acid (P<0.05 vs. MPTP mice on control diet) in the striatum. Taken together, these data suggest that a high n-3 PUFA dietary intake exerts neuroprotective actions in an animal model of Parkinsonism.
引用
收藏
页码:1213 / 1225
页数:13
相关论文
共 90 条
[51]   A diet enriched with the omega-3 fatty acid docosahexaenoic acid reduces amyloid burden in an aged Alzheimer mouse model [J].
Lim, GP ;
Calon, F ;
Morihara, T ;
Yang, FS ;
Teter, B ;
Ubeda, O ;
Salem, N ;
Frautschy, SA ;
Cole, GM .
JOURNAL OF NEUROSCIENCE, 2005, 25 (12) :3032-3040
[52]  
Maclean C H, 2005, Evid Rep Technol Assess (Summ), P1
[53]   Fatty acid composition in major depression: Decreased omega 3 fractions in cholesteryl esters and increased C20:4 omega 6/C20:5 omega 3 ratio in cholesteryl esters and phospholipids [J].
Maes, M ;
Smith, R ;
Christophe, A ;
Cosyns, P ;
Desnyder, R ;
Meltzer, H .
JOURNAL OF AFFECTIVE DISORDERS, 1996, 38 (01) :35-46
[54]   DNA damage in brain mitochondria caused by aging and MPTP treatment [J].
Mandavilli, BS ;
Ali, SF ;
Van Houten, B .
BRAIN RESEARCH, 2000, 885 (01) :45-52
[55]   Profound astrogenesis in the striatum of adult mice following nigrostriatal dopaminergic lesion by repeated MPTP administration [J].
Mao, LM ;
Lau, YS ;
Petroske, E ;
Wang, JQ .
DEVELOPMENTAL BRAIN RESEARCH, 2001, 131 (1-2) :57-65
[56]   A simplified and efficient method for the analysis of fatty acid methyl esters suitable for large clinical studies [J].
Masood, A ;
Stark, KD ;
Salem, N .
JOURNAL OF LIPID RESEARCH, 2005, 46 (10) :2299-2305
[57]  
McGeer PL, 2001, ADV NEUROL, V86, P83
[58]   Modulation of phosphoinositide-protein kinase C signal transduction by omega-3 fatty acids: Implications for the pathophysiology and treatment of recurrent neuropsychiatric illness [J].
McNamara, Robert K. ;
Ostrander, Michelle ;
Abplanalp, William ;
Richtand, Nell M. ;
Benoit, Stephen C. ;
Clegg, Debbie J. .
PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS, 2006, 75 (4-5) :237-257
[59]   Dopamine transporters and neuronal injury [J].
Miller, GW ;
Gainetdinov, RR ;
Levey, AI ;
Caron, MG .
TRENDS IN PHARMACOLOGICAL SCIENCES, 1999, 20 (10) :424-429
[60]  
Mizuno Y, 2001, ADV NEUROL, V86, P13